
==== Front
Arch Virol
Arch. Virol
Archives of Virology
0304-8608 1432-8798 Springer-Verlag Vienna 

6249243
BF01320618
10.1007/BF01320618
Original Papers
Prepubertal vaccination of mice against experimental infection of the genital tract with type 2 herpes simplex virus
Skinner G. R. B.  Williams D. R.  Moles A. W.  Sargent A.  grid.1006.70000000104627212Department of Medical Microbiology, The Medical School, Birmingham, England 
1980 
64 4 329 338
22 10 1979 30 1 1980 © Springer-Verlag 1980This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.Summary
Pre-pubertal immunisation of mice with a formalin-inactivated type 1 and 2 herpes simplex virus vaccine conferred a level of life-long protection against primary type 2 genital infection. Protection levels were better with type 1 vaccine and strikingly influenced by vaccine dosage where a one-hundred-fold reduction from the standard vaccine dosage diminished protection to insignificant levels. Vaccine efficacy was not significantly affected by the method of virus inactivation, the number of immunisations or the age of the mouse at immunisation. Vaccination conferred better protection than previous type 2 genital infection; this may be a consequence of a higher antigenic dose, more acceptable antigenic presentation or to a perversion of the immune response in a latently infected animal to homologous virus challenge.

Keywords
Herpes SimplexVirus VaccineInfected AnimalGenital TractExperimental Infectionissue-copyright-statement© Springer-Verlag 1980
==== Body
With 6 Figures
==== Refs
References
1. Adam E.  Kaufman R. H.  Melnick R. H.  Levy A. H.  Rawls W. E.   Seroepidemiologic studies of herpes virus type 2 and carcinoma of the cervix IV Amer. J. Epidemiol. 1974 98 77 
2. Anderson W. A.  Kilbourne E. D.   Immunization of mice with inactivated herpes simplex virus Proc. Soc. exp. Biol. Med. 1961 107 518 13683291 
3. Asher L. V. S.  Walz M. A.  Notkins A. L.   Effect of immunization on the development of latent ganglionic infection in mice challenged intravaginally with herpes simplex virus types 1 and 2 Am. J. Obstet. Gynecol. 1978 131 788 210669 
4. Benda R.  Dbaly V.   Immunogenic properties of formalin herpes antigen prepared from cell cultures J. Hyg., Epidemiol., Microbiol., Immunol. 1973 17 237 
5. Duff R.  Rapp F.   Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2 Nature 1971 233 48 12058739 
6. Ennis F. A.   Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells J. inf. Dis. 1973 127 632 4350518 
7. Geder L.  Skinner G. R. B.   Differentiation between type 1 and type 2 strains of herpes simplex virus by an indirect immunofluorescent technique J. gen. Virol. 1971 12 179 4330789 
8. Kitces E. N.  Morahan P. S.  Tew J. G.  Murray B. K.   Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine Infect. Immun. 1977 16 955 197013 
9. Lipchutz B.   Untersuchungen über die Ätiologie der Krankheiten der Herpesgruppe Arch. Derm. Syph. 1921 136 428 
10. MacPherson I.  Stoker M.   Polyoma transformation of hamster cell clones—an investigation of genetic factors affecting cell competence Virology 1962 16 147 14468055 
11. McKendall R. R.   Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice Infect. Immun. 1977 16 717 193798 
12. McNab J. C. M.   Transformation of rat embryo cells by temperature sensitive mutants of herpes simplex virus J. gen. Virol. 1974 24 143 4367306 
13. Nahmias A. J.  Josey W. E.  Naib Z. M.  Lucé C. F.  Duffey A.   Antibodies toHerpesvirus hominis  types 1 and 2 in humans. I. Patients with genital infections Amer. J. Epidemiol. 1970 91 539 4315623 
14. Nahmias A. J.  Roizman B.   Infection with herpes simplex viruses 1 and 2 N. Engl. J. Med. 1973 289 719 4353782 
15. Pauls F. P.  Dowdle W. R.   A serological study ofHerpesvirus hominis  strains by microneutralisation tests J. Immunol. 1967 98 941 4290495 
16. Plummer G.  Goodheart C. R.  Miyagi M.  Skinner G. R. B.  Thouless M. E.  Wildy P.   Herpes simplex viruses: Discrimination of types and correlation between different characteristics Virology 1974 60 206 4366799 
17. Price R. W.  Walz M. A.  Wohlenberg C.  Notkins A. L.   Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunisation Science 1975 188 938 166432 
18. Rager-Zisman B.  Allison A. C.   Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection J. Immunol. 1976 116 35 173758 
19. Rawls W. E.  Gardner H. L.  Flanders R. W.  Lowry S. P.  Kaufman R. H.  Melnick J. L.   Genital herpes in two social groups Amer. J. Obstet. Gynecol. 1971 110 682 4327432 
20. Russell W. C.   A sensitive and precise plaque assay for herpes virus Nature 1962 195 1028 14495438 
21. Sim C.  Watson D. H.   The role of type-specific and cross-reacting structural antigens in the neutralisation of herpes simplex virus types 1 and 2 J. gen. Virol. 1973 19 217 4351780 
22. Skinner G. R. B.   Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a ‘hit-and-run’ mechanism Brit. J. exp. Pathol. 1976 57 361 183803 
23. Skinner, G. R. B., Hartley, C. E., Moles, A. W., Williams, D. R., Buchan, A.: The preparation, efficacy and safety of a herpes simplex vaccine for human subjects. (In preparation.)
24. Skinner G. R. B.  Taylor J.  Edwards J.   Precipitating antibodies to herpes simplex virus in human sera: a prevalence of antibody to common antigen (Band II) Intervirology 1975 4 320 
25. Skinner G. R. B.  Thouless M. E.  Edwards J.  Trueman S.  Gibbs A. J.   Sero-relatedness of type 1 and type 2 herpes simplex virus; type-specificity of antibody response Immunology 1976 31 481 194831 
26. Skinner G. R. B.  Whitney J. E.  Hartley C.   Prevalence of type-specific antibody against type 1 and type 2 herpes simplex virus in women with abnormal cervical cytology; evidence towards pre-pubertal vaccination of sero-negative female subjects Arch. Virol. 1977 54 211 196578 
27. Skinner G. R. B.  Williams D. R.  Buchan A.  Whitney J.  Harding M.  Bodfish K.   Preparation and efficacy of an inactivated sub-unit vaccine (NFU BHK) against type 2 herpes simplex virus infection Med. Microbiol. Immunol. 1978 166 119 214676 
28. Vantsis J. F.  Wildy P.   Interaction of herpes virus and HeLa cells: comparison of cell killing and infective centre formation Virology 1962 17 225 13924786 
29. Walz M. A.  Price R. W.  Hayashi K.    Effect of immunization on acute and latent infection of vagino-uterine tissue with herpes simplex virus types 1 and 2 J. inf. Dis. 1977 135 744 192810 
30. Wildy P.   Recombination with herpes simplex virus J. gen. Microbiol. 1955 13 340 
31. Williams D. R.  Whitney J.  Harding M.  Bodfish K.  Skinner G. R. B.   Cytological evaluation of experimental type 2 herpes simplex infection in mice Acta Cytologica 1978 22 41

